Ganesh Pusapati

Dr. Ganesh Pusapati


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Cell
Verified
Journal Article
Closed access
SPSiew Cheng Phua
Siew Cheng Phua
SCShuhei Chiba
Shuhei Chiba
MSMasako Suzuki
Masako Suzuki
ESEmily Su
Emily Su
ERElle C. Roberson
Elle C. Roberson
TITakanari Inoue
Takanari Inoue

29 April 2015 in Nature
Verified
Journal Article
Open access
PDF file
YCYaron Carmi
Yaron Carmi
MSMatthew H. Spitzer
Matthew H. Spitzer
ILIan L. Linde
Ian L. Linde
BBBryan M. Burt
Bryan M. Burt
TPTyler R. Prestwood
Tyler R. Prestwood
EEEdgar G. Engleman
Edgar G. Engleman
Naturally occurring tumour-binding IgG antibodies are shown to initiate the rejection of allogeneic tumours, whereby Fc-receptor-mediated uptake of tumour immune complexes into dendritic cells activates tumour-reactive T cells, and intra-tumoral injection of allogeneic IgG together with dendritic cell adjuvants induces systemic T-cell-mediated antitumour responses. Cancers generally evade host immune responses yet tumours are not transmissible between individuals, suggesting that the immune system does have the ability to recognize and kill tumour cells. This study of the fate of transplanted allogeneic tumours in mice shows that their rejection is initiated by naturally occurring tumour-binding IgG antibodies. Fcγ-receptor-mediated uptake of tumour immune complexes into dendritic cells activates tumour-reactive T cells, and intra-tumoral injection of allogeneic IgG together with dendritic cell adjuvants induces systemic T-cell-mediated antitumour responses. This work reveals a novel mechanism of tumour rejection that might be exploited clinically. Whereas cancers grow within host tissues and evade host immunity through immune-editing and immunosuppression1,2,3,4,5, tumours are rarely transmissible between individuals. Much like transplanted allogeneic organs, allogeneic tumours are reliably rejected by host T cells, even when the tumour and host share the same major histocompatibility complex alleles, the most potent determinants of transplant rejection6,7,8,9,10. How such tumour-eradicating immunity is initiated remains unknown, although elucidating this process could provide the basis for inducing similar responses against naturally arising tumours. Here we find that allogeneic tumour rejection is initiated in mice by naturally occurring tumour-binding IgG antibodies, which enable dendritic cells (DCs) to internalize tumour antigens and subsequently activate tumour-reactive T cells. We exploited this mechanism to treat autologous and autochthonous tumours successfully. Either systemic administration of DCs loaded with allogeneic-IgG-coated tumour cells or intratumoral injection of allogeneic IgG in combination with DC stimuli induced potent T-cell-mediated antitumour immune responses, resulting in tumour eradication in mouse models of melanoma, pancreas, lung and breast cancer. Moreover, this strategy led to eradication of distant tumours and metastases, as well as the injected primary tumours. To assess the clinical relevance of these findings, we studied antibodies and cells from patients with lung cancer. T cells from these patients responded vigorously to autologous tumour antigens after culture with allogeneic-IgG-loaded DCs, recapitulating our findings in mice. These results reveal that tumour-binding allogeneic IgG can induce powerful antitumour immunity that can be exploited for cancer immunotherapy.

30 October 2019 in eLife
Verified
Journal Article
Open access
MKMaia Kinnebrew
Maia Kinnebrew
EIEllen J Iverson
Ellen J Iverson
BPBhaven B Patel
Bhaven B Patel
GPGanesh Pusapati
Ganesh Pusapati
JKJennifer H Kong
Jennifer H Kong
RRRajat Rohatgi
Rajat Rohatgi
Previously we proposed that transmission of the hedgehog signal across the plasma membrane by Smoothened is triggered by its interaction with cholesterol (Luchetti et al., 2016). But how is cholesterol, an abundant lipid, regulated tightly enough to control a signaling system that can cause birth defects and cancer? Using toxin-based sensors that distinguish between distinct pools of cholesterol, we find that Smoothened activation and hedgehog signaling are driven by a biochemically-defined, small fraction of membrane cholesterol, termed accessible cholesterol. Increasing cholesterol accessibility by depletion of sphingomyelin, which sequesters cholesterol in complexes, amplifies hedgehog signaling. Hedgehog ligands increase cholesterol accessibility in the membrane of the primary cilium by inactivating the transporter-like protein Patched 1. Trapping this accessible cholesterol blocks hedgehog signal transmission across the membrane. Our work shows that the organization of cholesterol in the ciliary membrane can be modified by extracellular ligands to control the activity of cilia-localized signaling proteins.

1 January 2018 in Developmental Cell
Verified
Journal Article
Open access
GPGanesh Pusapati
Ganesh Pusapati
JKJennifer H. Kong
Jennifer H. Kong
BPBhaven B. Patel
Bhaven B. Patel
AKArunkumar Krishnan
Arunkumar Krishnan
ASAndreas Sagner
Andreas Sagner
RRRajat Rohatgi
Rajat Rohatgi
To uncover regulatory mechanisms in Hedgehog (Hh) signaling, we conducted genome-wide screens to identify positive and negative pathway components and validated top hits using multiple signaling and differentiation assays in two different cell types. Most positive regulators identified in our screens, including Rab34, Pdcl, and Tubd1, were involved in ciliary functions, confirming the central role for primary cilia in Hh signaling. Negative regulators identified included Megf8, Mgrn1, and an unannotated gene encoding a tetraspan protein we named Atthog. The function of these negative regulators converged on Smoothened (SMO), an oncoprotein that transduces the Hh signal across the membrane. In the absence of Atthog, SMO was stabilized at the cell surface and concentrated in the ciliary membrane, boosting cell sensitivity to the ligand Sonic Hedgehog (SHH) and consequently altering SHH-guided neural cell-fate decisions. Thus, we uncovered genes that modify the interpretation of morphogen signals by regulating protein-trafficking events in target cells.

2 November 2010 in Circulation
Verified
Journal Article
Closed access
PDF file
AKAlexander Kleger
Alexander Kleger
TSThomas Seufferlein
Thomas Seufferlein
DMDaniela Malan
Daniela Malan
MTMichael Tischendorf
Michael Tischendorf
ASAlexander Storch
Alexander Storch
SLStefan Liebau
Stefan Liebau
Background—: Ion channels are key determinants for the function of excitable cells, but little is known about their role and involvement during cardiac development. Earlier work identified Ca 2+ -activated potassium channels of small and intermediate conductance (SKCas) as important regulators of neural stem cell fate. Here we have investigated their impact on the differentiation of pluripotent cells toward the cardiac lineage. Methods and Results—: We have applied the SKCa activator 1-ethyl-2-benzimidazolinone on embryonic stem cells and identified this particular ion channel family as a new critical target involved in the generation of cardiac pacemaker-like cells: SKCa activation led to rapid remodeling of the actin cytoskeleton, inhibition of proliferation, induction of differentiation, and diminished teratoma formation. Time-restricted SKCa activation induced cardiac mesoderm and commitment to the cardiac lineage as shown by gene regulation, protein, and functional electrophysiological studies. In addition, the differentiation into cardiomyocytes was modulated in a qualitative fashion, resulting in a strong enrichment of pacemaker-like cells. This was accompanied by induction of the sino-atrial gene program and in parallel by a loss of the chamber-specific myocardium. In addition, SKCa activity induced activation of the Ras-Mek-Erk signaling cascade, a signaling pathway involved in the 1-ethyl-2-benzimidazolinone–induced effects. Conclusions—: SKCa activation drives the fate of pluripotent cells toward mesoderm commitment and cardiomyocyte specification, preferentially into nodal-like cardiomyocytes. This provides a novel strategy for the enrichment of cardiomyocytes and in particular, the generation of a specific subtype of cardiomyocytes, pacemaker-like cells, without genetic modification.

6 February 2018 in Science Signaling
Verified
Journal Article
Closed access
GPGanesh Pusapati
Ganesh Pusapati
JKJennifer H. Kong
Jennifer H. Kong
BPBhaven B. Patel
Bhaven B. Patel
MGMina Gouti
Mina Gouti
ASAndreas Sagner
Andreas Sagner
RRRajat Rohatgi
Rajat Rohatgi
Gα s protein–coupled receptors reduce the sensitivity of cells to the morphogen Sonic Hedgehog.